ALNYLAM PHARMACEUTICALS INCALNYLAM PHARMACEUTICALS INCALNYLAM PHARMACEUTICALS INC

ALNYLAM PHARMACEUTICALS INC

No trades
See on Supercharts

Price target

6,160.230.000.00%
The 26 analysts offering 1 year price forecasts for ALNY have a max estimate of — and a min estimate of —.

Analyst rating

Based on 33 analysts giving stock ratings to ALNY in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ALNY EPS for the last quarter is −17.14 MXN despite the estimation of −18.06 MXN. In the next quarter EPS is expected to reach −11.37 MXN. Track more of ALNYLAM PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter ALNYLAM PHARMACEUTICALS INC revenue is expected to reach ‪11.73 B‬ MXN. Check out ALNYLAM PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, ALNY price target is 6,160.23 MXN with a max estimate of 8,058.67 MXN and a min estimate of 3,586.11 MXN. Check if this forecast comes true in a year, meanwhile watch ALNYLAM PHARMACEUTICALS INC stock price chart and keep track of the current situation with ALNY news and stock market news.
We've gathered opinions of 33 analysts rating ALNY stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.